| 000 | 01302 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250513224857.0 | ||
| 264 | 0 | _c20010531 | |
| 008 | 200105s 0 0 eng d | ||
| 022 | _a8755-6863 | ||
| 024 | 7 |
_a10.1002/1099-0496(200012)30:6<481::aid-ppul8>3.0.co;2-n _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGysin, C | |
| 245 | 0 | 0 |
_aSinonasal disease in cystic fibrosis: clinical characteristics, diagnosis, and management. _h[electronic resource] |
| 260 |
_bPediatric pulmonology _cDec 2000 |
||
| 300 |
_a481-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCystic Fibrosis _xcomplications |
| 650 | 0 | 4 | _aEndoscopy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aNasal Mucosa _xpathology |
| 650 | 0 | 4 |
_aNasal Polyps _xetiology |
| 650 | 0 | 4 |
_aParanasal Sinus Diseases _xetiology |
| 650 | 0 | 4 |
_aPseudomonas Infections _xdrug therapy |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 |
_aTobramycin _xtherapeutic use |
| 700 | 1 | _aAlothman, G A | |
| 700 | 1 | _aPapsin, B C | |
| 773 | 0 |
_tPediatric pulmonology _gvol. 30 _gno. 6 _gp. 481-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/1099-0496(200012)30:6<481::aid-ppul8>3.0.co;2-n _zAvailable from publisher's website |
| 999 |
_c11050345 _d11050345 |
||